DUBLIN–(BUSINESS WIRE)–The “Next Generation Biologics Market Analysis by Type (Regenerative Medicine, Antibodies, Insulin, Growth Hormones), by Application (Scientific Research, Medical), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering.
The global market size for next generation biologics products is estimated to be USD 5,981.6 million in 2021 and is expected to witness a CAGR of 8.85% during the forecast period.
Rising demand for ADCs, technological advancements, growing reimbursement support, and escalating investment in R&D are the major factors driving the global next generation biologics market. However, various factors such as complexities in manufacturing of biologics, complicated regulatory framework, and difficulties in patient recruitment for conducting clinical trials, high cost, and failure rate in clinical trials are hindering the market growth.
Next Generation Biologics Market, By Type (Revenue, 2021-2029, USD Million)
- Regenerative medicine
- Antibodies
- Growth hormones
- Insulin
- Other
Next Generation Biologics Market, By Application (Revenue, 2021-2029, USD Million)
- Scientific Research
- Medical
- Other
Next Generation Biologics Market, By Region (Revenue, 2021-2029, USD Million)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of MEA
Key Topics Covered:
1. Research Methodology
2. Introduction: Next Generation Biologics
3. Executive Summary
4. Market Dynamics
5. Market Environment Analysis
6. COVID-19 Impact Analysis: Next Generation Biologics Market
7. Market Analysis by Type
8. Market Analysis by Application
9. Regional Market Analysis
10. North America Next Generation Biologics Market
11. Europe Next Generation Biologics Market
12. Asia Pacific Next Generation Biologics Market
13. Latin America Next Generation Biologics Market
14. MEA Next Generation Biologics Market
15. Competitor Analysis
16. Company Profiles
17. Conclusion & Recommendations
Companies Mentioned
- Novo Nordisk (Denmark)
- Biogen Inc. (U.S.)
- Roche Holding AG (Switzerland)
- Pfizer Inc. (U.S.)
- Molecular Partners AG (Switzerland)
- Sanofi S.A. (France)
- Eli Lilly and Company (U.S.)
- Mitsubishi Group (Japan)
- AbbVie Inc. (U.S.)
- Bayer AG (Germany)
For more information about this report visit https://www.researchandmarkets.com/r/o537n1
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
